Final pooled data from Phase II studies (AIRLEAF®​, CLAIRLEAF®​) of the dipeptidyl peptidase 1 (or Cathepsin C) inhibitor verducatib in bronchiectasis

M Shteinberg, W Sauter, A Eleftheraki, S H Chotirmall, P A Flume, R Jain, K Morimoto, A E O’Donnell, F C Ringshausen, H Watz, J F Xu, J Rauch, O Körsgen, M A Mall, A Gupta, J D Chalmers · Pneumologie · 2026 · Heft S 02 S 02 · S. e73-e74